19 June 2013
Keywords: priority, review, roche, pegasys, sbla, food, drug
Article | 11 October 2004
The US Food and Drug Administration has granted a six-month priority review to Roche's supplemental Biologics License Application for use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 October 2004
4 October 2004
© 2013 thepharmaletter.com